Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Our AI ranks Natural Alternatives International Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Natural Alternatives International Inc is a small-cap company with a market capitalization of $7M. It ranks number 22 by market capitalization among the 28 Medicinal Chemicals & Botanical Products issuers in our coverage with a current forecast. Its P/B Ratio of 0.14x is the lowest of the 13 peers that report one. Its Gross Margin of 6.3% is the lowest of the 23 peers that report one.
For NAII, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 23.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 3.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, NAII included.
Follow NAII free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Medicinal Chemicals & Botanical Products peers listed below that report each metric.
| Metric | NAII | Rank |
|---|---|---|
| Market Cap | $7M | 22/28 |
| P/B Ratio | 0.14x | 13/13 |
| EPS | $-3.43 | – |
| Book Value/Share | $8.09 | – |
| Revenue/Share | $23.09 | – |
| FCF/Share | $-2.04 | – |
| Metric | NAII | Rank |
|---|---|---|
| ROE | -41.4% | 12/16 |
| ROA | -16.4% | 14/24 |
| ROIC | -21.1% | 15/20 |
| Gross Margin | 6.3% | 23/23 |
| Operating Margin | -13.2% | 12/24 |
| Net Margin | -14.5% | 10/22 |
| EBT Margin | -14.2% | 13/25 |
| Tax Rate | -2.1% | – |
| Metric | NAII | Rank |
|---|---|---|
| Current Ratio | 1.73x | 12/28 |
| Quick Ratio | 0.92x | 12/26 |
| D/E Ratio | 1.53x | 6/17 |
| Financial Leverage | 2.53x | 6/17 |
| Interest Coverage | 28.3x | 4/22 |
| Working Capital | $28M | 13/28 |
| Metric | NAII | Rank |
|---|---|---|
| Operating Cash Flow | -$9M | 24/29 |
| Free Cash Flow | -$13M | 10/12 |
| Capital Spending | -$4M | 5/12 |
| OCF Growth YoY | -250.3% | 10/11 |
| FCF Growth YoY | -644.3% | 6/6 |
| FCF/Sales | -8.8% | 10/12 |
| CapEx/Sales | 2.6% | 5/12 |
| Metric | NAII | Rank |
|---|---|---|
| Asset Turnover | 1.13x | 6/17 |
| Receivables Turnover | 6.9x | 13/16 |
| Inventory Turnover | 4.3x | 4/21 |
| Fixed Assets Turnover | 4.0x | 8/17 |
| Days Sales Outstanding | 53 days | 4/16 |
| Days Inventory | 84 days | 17/20 |
| Payables Period | 50 days | 10/18 |
| Cash Conversion Cycle | 87 days | 10/12 |
| Metric | NAII | Rank |
|---|---|---|
| Total Revenue | $143M | 11/18 |
| Operating Income | -$19M | 20/27 |
| Net Income | -$21M | 15/24 |
| SG&A Expense | $17M | 12/16 |
| Cost of Goods Sold | $134M | 6/24 |
| Metric | NAII | Rank |
|---|---|---|
| Shares Outstanding | 6M | – |
| Total Current Assets | $65M | 52.0% of assets |
| Cash & Short-term Investments | $7M | 5.9% of assets |
| Accounts Receivable | $21M | 16.4% of assets |
| Inventory | $31M | 24.4% of assets |
| Total Liabilities | $76M | 60.8% of assets |
| Short-term Debt | $20M | 15.6% of assets |
Companies classified under the same SEC industry code as Natural Alternatives International Inc (Medicinal Chemicals & Botanical Products): 32 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| NAII Natural Alternatives International Inc | ▲ | $7M |
| DFTX Definium Therapeutics, Inc. | ▲ | $4.31B |
| TRLV Trulieve Cannabis Corp. | ▲ | $1.93B |
| CRON Cronos Group Inc. | ▶ | $1.18B |
| TLRY Tilray Brands, Inc. | ▼ | $414M |
| SNDL Sndl Inc. | ▶ | $322M |
| CGC Canopy Growth Corp | ▶ | $302M |
| GLAS Glass House Brands Inc. | ▼ | $301M |
| USNA Usana Health Sciences Inc | ▼ | $287M |
| ACB Aurora Cannabis Inc | ▶ | $253M |
| NAGE Niagen Bioscience, Inc. | ▶ | $197M |
| MDWD Mediwound Ltd. | ▶ | $157M |
| FTLF Fitlife Brands, Inc. | ▲ | $81M |
| AAWH Ascend Wellness Holdings, Inc. | ▲ | $80M |
| BTMD Biote Corp. | ▲ | $32M |
| MRMD Marimed Inc. | ▲ | $23M |
| CFOO China Foods Holdings Ltd. | ▼ | $21M |
| MTEX Mannatech Inc | ▲ | $14M |
| ADIA Adia Med, Inc. | ▲ | $13M |
| CHUC Charlie's Holdings, Inc. | ▼ | $13M |
| GLUC Glucose Health, Inc. | ▼ | $10M |
| BON Bon Natural Life Ltd | ▶ | $7M |
| PLSH Panacea Life Sciences Holdings, Inc. | ▲ | $6M |
| CYAN Cyanotech Corp | ▲ | $5M |
| IMCC Im Cannabis Corp. | ▼ | $2M |
| AIBT Aibotics, Inc. | ▼ | $2M |
| NPHC Nutra Pharma Corp | ▼ | $720K |
| MEHA Functional Brands Inc. | ▼ | $310K |
| CBDY Target Group Inc. | ▼ | N/A |
| HYEX Healthy Extracts Inc. | ▶ | N/A |
| NTRR Neutra Corp. | ▼ | N/A |
| SNYRQ Synergy Chc Corp. | ▼ | N/A |
CARLSBAD, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional ...
CARLSBAD, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional ...
Natural Alternatives International, Inc. reported earnings results for the full year ended June 30, 2026. For the full year, the company reported sales was USD 142.52 million compared to USD 129.86 ...
Our AI ranks Natural Alternatives International Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
For NAII, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 23.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 3.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Natural Alternatives International Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
32 issuers in our coverage, NAII included, share the SEC industry code Medicinal Chemicals & Botanical Products. The largest are: Definium Therapeutics, Inc. (DFTX), Trulieve Cannabis Corp. (TRLV), Cronos Group Inc. (CRON), Tilray Brands, Inc. (TLRY), Sndl Inc. (SNDL), Canopy Growth Corp (CGC).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.